QT
SCMP

Quantbot Technologies’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Quantbot Technologies’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,838
Closed -$29K – 1569
2017
Q2 		$29K Buy
2,838
+165
+6% +$1.68K ﹤0.01% 968
2017
Q1 		$29K Buy
+2,673
New +$31K ﹤0.01% 976
2016
Q3 		– Sell
-14,903
Closed -$163K – 1469
2016
Q2 		$163K Buy
14,903
+13,335
+850% +$149K 0.02% 614
2016
Q1 		$17K Buy
+1,568
New +$19.8K ﹤0.01% 1023
2015
Q4 		– Sell
-10,589
Closed -$210K – 1556
2015
Q3 		$210K Buy
+10,589
New +$243K 0.04% 519

Other funds holding SCMP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Quantbot Technologies's SCMP Position: Q3 2017 in Review

Quantbot Technologies sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q3 2017, closing a stake of 2,838 shares — an estimated $29K sold.

Quantbot Technologies first reported a position in SCMP in Q3 2015 and held it in 5 quarters. The position peaked at $210K in Q3 2015. 178 funds tracked by Wall St. Rank hold SCMP as of Q3 2017.

  • Quantbot Technologies reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
  • Quantbot Technologies sold 2,838 Sucampo Pharmaceuticals, Inc. shares in Q3 2017, an estimated $29K.
  • Quantbot Technologies first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2015 and held it in 5 quarters.
  • Quantbot Technologies's Sucampo Pharmaceuticals, Inc. position peaked at $210K in Q3 2015.
  • 178 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q3 2017.

Based on Quantbot Technologies's 13F filing for Q3 2017, filed 7 Nov 2017.